Inger Sandlie

Director/Miembro de la Junta en Radiumhospitalets Forskningsstiftelse .

71 años

Finance

Consumer Services

Health Technology

Perfil

Inger Sandlie is the founder of Nykode Therapeutics ASA, founded in 2006, and Nextera AS, founded in 2009.
At Nextera AS, she held the title of Scientific Advisor.
Currently, Dr. Sandlie holds the position of Director at Radiumhospitalets Forskningsstiftelse and the title of Professor at the University of Oslo.

Cargos activos de Inger Sandlie

Empresas	Cargo	Inicio
Radiumhospitalets Forskningsstiftelse Radiumhospitalets Forskningsstiftelse Financial ConglomeratesFinance Radiumhospitalets Forskningsstiftelse invests in companies from Nordic research institutions. It is a pre-seed investor and project developer focused on cancer. It strengthens cancer research at Rikshospitalet University Hospital, including The Norwegian Radium Hospital. It provides Oslo Cancer Cluster with the necessary infrastructure and management team, as well. The company was founded in 1986 and is headquartered in Lysaker, Norway.	Director/Miembro de la Junta	-
University of Oslo	Corporate Officer/Principal	-

Todos los cargos activos de Inger Sandlie

Antiguos cargos conocidos de Inger Sandlie.

Empresas	Cargo	Fin
NYKODE THERAPEUTICS	Fundador	-
Nextera AS Nextera AS Miscellaneous Commercial ServicesCommercial Services Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway.	Fundador	-

Ver el detalle de la experiencia de Inger Sandlie.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Inger Sandlie.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
NYKODE THERAPEUTICS	Health Technology

Empresas privadas	2
Radiumhospitalets Forskningsstiftelse Radiumhospitalets Forskningsstiftelse Financial ConglomeratesFinance Radiumhospitalets Forskningsstiftelse invests in companies from Nordic research institutions. It is a pre-seed investor and project developer focused on cancer. It strengthens cancer research at Rikshospitalet University Hospital, including The Norwegian Radium Hospital. It provides Oslo Cancer Cluster with the necessary infrastructure and management team, as well. The company was founded in 1986 and is headquartered in Lysaker, Norway.	Finance
Nextera AS Nextera AS Miscellaneous Commercial ServicesCommercial Services Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway.	Commercial Services